Back to dashboard

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)


The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms.

Apply Now

Don’t wait any longer! Easily apply for this grant to receive funds that are meant for you.

Apply Now
How to apply for grants?

Creating or growing your own venture can be a scary task — a task that often requires funding. It’s common when looking for funding to turn to banks and investors, but what if there was another option?

An option that has no cost.

Learn More